809 — Global Bio-chem Technology Co Income Statement
0.000.00%
- HK$584.95m
- HK$5.92bn
- HK$2.00bn
Annual income statement for Global Bio-chem Technology Co, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 849 | 747 | 12.7 | 1,374 | 2,001 |
Cost of Revenue | |||||
Gross Profit | 74.1 | 48.4 | 7.33 | 43.6 | 191 |
Selling / General / Administrative Expenses | |||||
Operating Interest Expense / Income | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,533 | 363 | 752 | -3,077 | 932 |
Operating Profit | -1,684 | 383 | -740 | 4,451 | 1,069 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2,411 | -409 | -1,425 | 3,701 | 746 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2,433 | -435 | -1,378 | 3,743 | 770 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -2,430 | -401 | -1,443 | 4,225 | 770 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2,430 | -401 | -1,443 | 4,225 | 770 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.241 | -0.14 | -0.145 | 0.048 | -0.002 |